Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Double Blind Placebo-Controlled Parallel Group Study Of Safety And Efficacy Of Isomyosamine In Treating Sarcopenia After Hip Or Femoral Fracture In Gerontological Population
Authors not listed
TNF Pharmaceuticals, Inc. · 2025
Abstract
This Phase II clinical study investigates the safety and effectiveness of a new drug, Isomyosamine, in patients with sarcopenia or frailty, conditions associated with aging and muscle weakness. Isomyosamine is a promising oral medication that reduces inflammation by targeting cytokines like TNF-α and IL-6, which are linked to these conditions. Previous studies have shown it is well-tolerated and may help improve muscle strength, mobility, and healing after hip fractures. This trial aims to determine its potential benefits in reducing inflammation and improving recovery in elderly patients.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-18 MST
Cite this
APA
Anonymous. (2025). Double Blind Placebo-Controlled Parallel Group Study Of Safety And Efficacy Of Isomyosamine In Treating Sarcopenia After Hip Or Femoral Fracture In Gerontological Population. <em>TNF Pharmaceuticals, Inc.</em>. https://clinicaltrials.gov/study/NCT06942182
Vancouver
Anonymous. Double Blind Placebo-Controlled Parallel Group Study Of Safety And Efficacy Of Isomyosamine In Treating Sarcopenia After Hip Or Femoral Fracture In Gerontological Population. TNF Pharmaceuticals, Inc.. 2025.
BibTeX
@misc{anon2025Double,
title = {Double Blind Placebo-Controlled Parallel Group Study Of Safety And Efficacy Of Isomyosamine In Treating Sarcopenia After Hip Or Femoral Fracture In Gerontological Population},
author = {Anonymous},
journal = {TNF Pharmaceuticals, Inc.},
year = {2025},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Elsevier eBooks 2016
Citation only
The Aging Muscle and Sarcopenia
Elsevier eBooks 2019
Citation only
Aging Muscle and Sarcopenia
Experimental Gerontology 2016
Citation only
Muscle function and fat content in relation to sarcopenia, obesity and frailty of old age — An overview
The Journal of Frailty & Aging 2014
Citation only
AGE, OBESITY, SARCOPENIA, AND PROXIMITY TO DEATH EXPLAIN REDUCED MEAN MUSCLE ATTENUATION IN PATIENTS WITH ADVANCED CANCER
DuPont Nutrition and Health 2013
Open access · US-GOV
A Randomized, Controlled Double Blind Acute Study: Effects of Protein Blends on Muscle Protein Synthesis and Breakdown in Healthy Older Adults
Clinical Nutrition ESPEN 2021
Citation only